Sign up
Quantellect · Congress · Trade Detail
NYSE: BIOBio-Rad Laboratories Inc
RepublicanHouse

James B. Renacci sold Bio-Rad Laboratories Inc (NYSE: BIO)

James B. Renacci (R-OH), a U.S. Representative, has disclosed 5 trades in Bio-Rad Laboratories Inc (BIO) since 2014, 1 purchase and 4 sales, worth an estimated $40K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: James B. Renacci sold $1,000 - $15,000 of Bio-Rad Laboratories Inc (NYSE: BIO) on July 24, 2018. Since that trade, BIO is up +6.25% against the S&P 500 up +191.82%, an outperformance of -185.57%.

Across these filings, James B. Renacci has been a net seller of BIO (a buy-to-sell ratio of 0.25). Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

BIO trades
5
Disclosed Vol
$40K
Buys
1
20%
Sells
4
80%
Buy / Sell
0.25
ratio
First → Last
2014–2018

James B. Renacci's BIO trades vs the price

BIO is up +6.25% since James B. Renacci sold on July 24, 2018, versus +191.82% for the S&P 500.

Performance since this trade

Price change since trade
+6.25%
S&P 500 change since trade
+191.82%
Outperformance vs S&P 500
-185.57%

All James B. Renacci BIO trades

TradedTypeSizeReturnEst. profit
July 24, 2018SELL$307.99+6.25%
June 28, 2018SELL$288.26+13.53%
February 8, 2017SELL$189.29+72.88%
August 20, 2015SELL$142.68+129.36%
October 30, 2014BUY$112.58+190.68%+$15K

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

James B. Renacci & BIO trading FAQ

Is it legal for James B. Renacci to trade Bio-Rad Laboratories Inc (BIO) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Bio-Rad Laboratories Inc (BIO), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did James B. Renacci sell BIO?

James B. Renacci disclosed a sale of $1,000 - $15,000 of Bio-Rad Laboratories Inc (BIO) on July 24, 2018, according to public STOCK Act filings.

How has BIO performed since James B. Renacci's trade?

Since James B. Renacci sold BIO on July 24, 2018, the stock is up +6.25%, versus +191.82% for the S&P 500 over the same period, an outperformance of -185.57%.

How many times has James B. Renacci traded BIO?

James B. Renacci has disclosed 5 BIO trades since 2014 (1 purchase and 4 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional BIO trades?

Quantellect tracks every disclosed congressional trade in Bio-Rad Laboratories Inc (BIO) on the Bio-Rad Laboratories Inc congressional trading page, which aggregates filings across all members of Congress.

James B. Renacci's BIO tradesAll congressional filings for Bio-Rad Laboratories IncJames B. Renacci's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.